Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 1999 - Dental Compounding
View All Articles in Issue

Abstract:  The US Food and Drug Administration has proposed that drug products listed in the table provided here be included on the list of drug products withdrawn or removed from the market because they have been found to be unsafe or ineffective. Therefore, compounding a drug product on this list would not be covered by the exemption provided in Section 503A(a) of the Federal Food and Drug Administration Modernization Act of 1997. The list originally appeared in the October 8, 1998, Federal Register (63[195]:54083-54087). Listings are mostly alphabetical. Reasons for withdrawal and withdrawal dates are also provided.

Related Keywords: Safety, Efficacy

Related Categories: LEGAL

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Allen Loyd V Jr Jan/Feb 1999 25-29 Buy
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J Jul/Aug 2004 313-319 Buy
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams Allen Loyd V Jr Sep/Oct 2020 356 Buy
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration Greeson Nicole MH, Mixon William, Allan W Chris Jul/Aug 2020 270-276 Buy
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Greeson Nicole MH, Mixon William, Allan W Chris Sep/Oct 2020 371-379 Buy
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Mixon Bill, Nain John May/Jun 2013 182-190 Buy
Quality Control: (Material) Safety Data Sheets Allen Loyd V Jr Mar/Apr 2017 118-124 Buy
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi Jul/Aug 2015 295-300 Buy
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety Prince Bryan, Lundeval Jeremy Nov/Dec 2013 485-489 Buy
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Ashe Krystina, Baskett Dustin Sep/Oct 2018 387-398 Buy